UY28676A1 - Nuevos compuestos - Google Patents

Nuevos compuestos

Info

Publication number
UY28676A1
UY28676A1 UY28676A UY28676A UY28676A1 UY 28676 A1 UY28676 A1 UY 28676A1 UY 28676 A UY28676 A UY 28676A UY 28676 A UY28676 A UY 28676A UY 28676 A1 UY28676 A1 UY 28676A1
Authority
UY
Uruguay
Prior art keywords
new compounds
relates
present
compounds
dimethylbenzylamino
Prior art date
Application number
UY28676A
Other languages
English (en)
Inventor
Lilljequist Lars
Lindqvist Maria
Nordberg Peter
Pettersson Ursula
Sebhatu Tesfai
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=30768770&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY28676(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of UY28676A1 publication Critical patent/UY28676A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a nuevas formas cristalinas de la sal mesilato de 2,3-dimetil-8-(2, 6-dimetilbencilamino)-N-hidroxietil-imidazopiridina-6-carboxamida y mezclas de las mismas. Asimismo, la presente invención se refiere a procesos para obtenerlos, el uso de dichos compuestos para el tratamiento de gastrointestinal trastornos y composiciones farmacéuticas que los contienen.
UY28676A 2003-12-18 2004-12-17 Nuevos compuestos UY28676A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0303451A SE0303451D0 (sv) 2003-12-18 2003-12-18 New compounds

Publications (1)

Publication Number Publication Date
UY28676A1 true UY28676A1 (es) 2005-07-29

Family

ID=30768770

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28676A UY28676A1 (es) 2003-12-18 2004-12-17 Nuevos compuestos

Country Status (25)

Country Link
US (1) US7459463B2 (es)
EP (1) EP1697360B1 (es)
JP (2) JP2007514744A (es)
KR (1) KR20060125803A (es)
CN (1) CN1894246B (es)
AR (1) AR046956A1 (es)
AT (1) ATE499371T1 (es)
AU (1) AU2004299435B2 (es)
BR (1) BRPI0417640A (es)
CA (1) CA2549144A1 (es)
CO (1) CO5721004A2 (es)
DE (1) DE602004031556D1 (es)
ES (1) ES2359829T3 (es)
HK (1) HK1095810A1 (es)
IL (1) IL175957A0 (es)
MX (1) MXPA06006708A (es)
MY (1) MY140450A (es)
NO (1) NO20063309L (es)
RU (1) RU2376306C2 (es)
SE (1) SE0303451D0 (es)
TW (1) TW200526659A (es)
UA (1) UA84443C2 (es)
UY (1) UY28676A1 (es)
WO (1) WO2005058895A1 (es)
ZA (1) ZA200604633B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1682133A1 (en) * 2003-11-03 2006-07-26 AstraZeneca AB Imidazo 1,2-a pyridine derivatives for the treatment of silent gastro-esophageal reflux
FI20086158A0 (fi) 2008-12-03 2008-12-03 Mikael Dahlstroem Imidatsopyridiinijohdannaiset

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4040632A1 (de) * 1990-12-19 1992-06-25 Kali Chemie Pharma Gmbh Phenylalkylaminoalkyl-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
SE512531C2 (sv) 1997-09-04 2000-03-27 Astacarotene Ab Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk förbättring av muskelfunktionsdurationen hos däggdjur och/eller behandling av muskelstörningar eller - sjukdomar hos däggdjur
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
SE0100295D0 (sv) 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100296D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100297D0 (sv) 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
WO2002064121A1 (en) 2001-02-13 2002-08-22 Astrazeneca Ab Novel modified released formulation
MXPA04011018A (es) * 2002-05-07 2005-01-25 Altana Pharma Ag Nueva combinacion de inhibidores reversibles de la bomba de protones y productos terapueticos para tratar trastornos de las vias respiratorias.

Also Published As

Publication number Publication date
AU2004299435B2 (en) 2008-04-17
AU2004299435A1 (en) 2005-06-30
UA84443C2 (ru) 2008-10-27
ES2359829T3 (es) 2011-05-27
JP2012102143A (ja) 2012-05-31
US7459463B2 (en) 2008-12-02
HK1095810A1 (es) 2007-05-18
RU2376306C2 (ru) 2009-12-20
IL175957A0 (en) 2006-10-05
MXPA06006708A (es) 2006-08-18
EP1697360A1 (en) 2006-09-06
CN1894246A (zh) 2007-01-10
JP2007514744A (ja) 2007-06-07
NO20063309L (no) 2006-09-14
ATE499371T1 (de) 2011-03-15
WO2005058895A1 (en) 2005-06-30
CA2549144A1 (en) 2005-06-30
CO5721004A2 (es) 2007-01-31
US20070112021A1 (en) 2007-05-17
DE602004031556D1 (de) 2011-04-07
CN1894246B (zh) 2011-06-22
EP1697360B1 (en) 2011-02-23
BRPI0417640A (pt) 2007-03-27
TW200526659A (en) 2005-08-16
MY140450A (en) 2009-12-31
AR046956A1 (es) 2006-01-04
SE0303451D0 (sv) 2003-12-18
KR20060125803A (ko) 2006-12-06
ZA200604633B (en) 2007-04-25
RU2006123362A (ru) 2008-01-27

Similar Documents

Publication Publication Date Title
HN2004000319A (es) "{ 1,8}naftiridin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia"
HN2002000275A (es) Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados
AR048912A1 (es) Inmunoglobulinas anti-nogo
UY28376A1 (es) Agentes terapéuticos
UY30314A1 (es) Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmacéuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
AR038047A1 (es) Agentes terapeuticos
ECSP088329A (es) Nuevos diazaespiroalcanos y su uso para el tratamiento de enfermedades mediadas por ccr8
PA8621901A1 (es) Derivados de sulfonamida para el tratamiento de enfermedades
GT200600161A (es) Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de los trastornos psicoticos
UY28374A1 (es) Agentes terapéuticos
UY28752A1 (es) Agentes terapeuticos
UY28342A1 (es) Nuevos compuestos
UY28510A1 (es) Compuestos quimicos
UY28369A1 (es) Agentes terapéuticos
UY28144A1 (es) Agentes terapéuticos
UY29893A1 (es) Derivados de pirazina
AR047922A1 (es) Nuevos derivados de pentafluorsulfanilo, su obtencion y su utilizacion como agentes farmaceuticos
AR054129A1 (es) Derivados de 2, 6-quinolinilo, una preparacion farmaceutica que los contiene y su empleo en la fabricacion de medicamentos para el tratamiento de enfermedades dependientes de integrinas alfa4beta1 y/o alfa4beta7
UY30048A1 (es) Derivados sustituidos de la n,2-(1h-benzimidazol-1-il) acetamida, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones
UY28839A1 (es) Agentes terapeuticos
UY29790A1 (es) Sales de diariloimidazola-4-carboxamidas, composiciones que las contienen, procesos de preparación y aplicaciones
HN2003000379A (es) Derivados de anilinopirazol utiles en el tratamiento de la diabetes
UY29741A1 (es) Sales de 1,5- diaril pirazol-3-carboxamidas, procesos de preparación, composeciones farmacéuticas que las contienen, aplicaciones y métodos de uso.
UY28377A1 (es) Agentes terapeuticos
PA8568101A1 (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso

Legal Events

Date Code Title Description
DESI Application deemed to be withdrawn

Effective date: 20120330